114 related articles for article (PubMed ID: 6340244)
1. Active and inactive renin after captopril (SQ 14225) administration in hypertensive patients.
Goto T; Abe K; Otsuka Y; Seino M; Ito T; Imai Y; Haruyama T; Sato M; Hiwatari M; Sato K; Omata K; Kasai Y; Tajima J; Yoshinaga K
Tohoku J Exp Med; 1983 Jan; 139(1):103-11. PubMed ID: 6340244
[TBL] [Abstract][Full Text] [Related]
2. Active and inactive renin after SQ 14225 (Captopril) administration.
Goto T; Abe K; Otsuka Y; Itoh T; Imai Y; Satoh M; Omata K; Yoshinaga K
Tohoku J Exp Med; 1980 Nov; 132(3):363-4. PubMed ID: 7008259
[TBL] [Abstract][Full Text] [Related]
3. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.
Imai Y; Abe K; Otsuka Y; Sakurai Y; Ito T; Sato M; Haruyama T; Omata K; Hiwatari M; Yoshinaga K
Jpn Heart J; 1980 Nov; 21(6):793-802. PubMed ID: 7007685
[TBL] [Abstract][Full Text] [Related]
4. Active and inactive renin after a single dose of captopril in hypertensive patients.
Glorioso N; Dessi Fulgheri P; Madeddu P; Fois G; Palermo M; Cocco F; Dettori S; Rappelli A
Am J Cardiol; 1982 Apr; 49(6):1552-4. PubMed ID: 7041596
[TBL] [Abstract][Full Text] [Related]
5. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
6. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225).
Imai Y; Abe K; Otsuka Y; Sakurai Y; Yoshinaga K
Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048
[TBL] [Abstract][Full Text] [Related]
7. [Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension].
Kutkuhn B; Chlebowski H; Hollenbeck M; Grabensee B
Z Kardiol; 1989 Mar; 78(3):204-10. PubMed ID: 2652907
[TBL] [Abstract][Full Text] [Related]
8. Effect of captopril and aprotinin on inactive renin.
Sealey JE; Overlack A; Laragh JH; Stumpe KO; Atlas SA
J Clin Endocrinol Metab; 1981 Sep; 53(3):626-30. PubMed ID: 6167591
[TBL] [Abstract][Full Text] [Related]
9. The effect of in vitro captopril and angiotensin II on plasma renin activity.
Roulston JE; Wathen CG
Clin Chim Acta; 1984 Mar; 138(1):99-103. PubMed ID: 6370512
[TBL] [Abstract][Full Text] [Related]
10. Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state.
de Bruyn JH; Wenting GJ; Man in 'T Veld AJ; Derkx FH; Schalekamp MA
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():83s-86s. PubMed ID: 7004742
[TBL] [Abstract][Full Text] [Related]
11. The changes in active and inactive renin induced by various maneuvers in hypertensive patients.
Goto T; Abe K; Tsunoda K; Seino M; Yasujima M; Imai Y; Chiba S; Sato M; Haruyama T; Omata K
Tohoku J Exp Med; 1986 Jun; 149(2):169-81. PubMed ID: 2944248
[TBL] [Abstract][Full Text] [Related]
12. Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
Abe K; Itoh T; Imai Y; Sato M; Haruyama T; Sakurai Y; Goto T; Otsuka Y; Yoshinaga K
Jpn Circ J; 1980 May; 44(5):422-5. PubMed ID: 6993721
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin inhibits the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
Abe K; Itoh T; Imai Y; Sato M; Goto T; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1980 Sep; 132(1):117-8. PubMed ID: 7010681
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandins inhibition on changes in active and inactive renin induced by antihypertensive drugs.
Salvetti A; Pedrinelli R; Sassano P; Arzilli F; Turini F
Clin Exp Hypertens A; 1982; 4(11-12):2435-48. PubMed ID: 6756707
[TBL] [Abstract][Full Text] [Related]
15. [Effect of captopril on renal vein plasma renin ratio--diagnosis and predicting response to surgery in renovascular hypertension].
Takata M; Sugimoto T; Mikawa M; Yoshida K; Iuchi K; Iida H; Mizumura Y; Nakada T; Kawahara Y
Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1017-26. PubMed ID: 6366302
[No Abstract] [Full Text] [Related]
16. Captopril in diuretic-treated hypertensive patients.
Koffer H; Vlasses PH; Ferguson RK; Weis M; Adler AG
JAMA; 1980 Dec; 244(22):2532-5. PubMed ID: 7001071
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of renovascular from essential hypertension by converting enzyme inhibition with an orally active compound.
Fagard R; Amery A; Lijnen P; Roussel-Deruyck R
Acta Clin Belg; 1982; 37(1):13-22. PubMed ID: 7046321
[No Abstract] [Full Text] [Related]
18. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
[No Abstract] [Full Text] [Related]
19. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
Sullivan JM; Ginsburg BA; Ratts TE; Johnson JG; Barton BR; Kraus DH; McKinstry DN; Muirhead EE
Hypertension; 1979; 1(4):397-401. PubMed ID: 232084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
